Chinese American Cancer Survivors Writing Study

Part of paid clinical trials in New York, New York.

Sponsor
New York University
Study ID
NCT05456100
Status
Recruiting

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Expressive Helping — BEHAVIORAL
    Expressive helping involves a combination of emotional disclosure and peer support writing completed over four weeks.
  • Expressive Writing — BEHAVIORAL
    Expressive writing involves emotional disclosure writing over four weeks.
  • Factual Writing — BEHAVIORAL
    Factual writing involves writing facts about cancer treatment and experiences over four weeks.

Study Details

The Chinese American Cancer Survivors Writing Study is a Randomized Controlled Trial (RCT) testing the feasibility and efficacy of the Expressive Helping (EH) intervention among Chinese American cancer survivors.

Key Dates

Start date
Jul 14, 2022
Status verified
May 2025
Primary completion
Jun 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
108 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Expressive Helping
    Participants complete a 20-minute expressive writing session once per week for the first three weeks. During Week 4, participants complete a 20-minute peer support writing session.
  • Active Comparator: Expressive Writing
    Participants complete a 20-minute expressive writing session once per week for four weeks.
  • Active Comparator: Factual Writing
    Participants complete a 20-minute factual writing about their cancer diagnosis and treatment every week for four weeks.

Primary Outcome Measure

Recruitment rates [ Time Frame: through study completion, an average of 6 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
New York UniversityNew YorkNew York10003
William Tsai
212-998-5552

Find similar trials in New York, NY

Related Studies